Review decisions
Showing 20 results of 2261 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1722628438095
Product Type: Drug
Control Number: 274939
DIN(s): 02550245, 02550253, 02550261
Manufacturer: Celltrion Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2023-06-30
Decision / Authorization Date: 2024-07-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1721931544640
Product Type: Drug
Control Number: 254159
DIN(s): 02462990, 02492393
Manufacturer: Hoffmann-La Roche Limited
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-06-25
Decision / Authorization Date: 2022-03-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1722952436074
Product Type: Drug
Control Number: 278042
DIN(s): 02527618
Manufacturer: Hoffmann-La Roche Limited
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-08-08
Decision / Authorization Date: 2024-07-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1723644947965
Product Type: Drug
Control Number: 275236
DIN(s): 02545713, 02545721
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2023-05-12
Decision / Authorization Date: 2024-02-28
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1722962428155
Product Type: Drug
Control Number: 273487
DIN(s): 02456869
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-20
Decision / Authorization Date: 2024-03-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1722614231303
Product Type: Drug
Control Number: 277017
DIN(s): 02535270
Manufacturer: Janssen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-07-07
Decision / Authorization Date: 2024-07-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1721416399864
Product Type: Drug
Control Number: 263226
DIN(s): 02547732
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-04-08
Decision / Authorization Date: 2024-05-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1722532649097
Product Type: Drug
Control Number: 281914
DIN(s): 02549891
Manufacturer: Merck Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Priority Review
Date Filed / Submission Date: 2023-12-08
Decision / Authorization Date: 2024-07-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1720539616626
Product Type: Drug
Control Number: 282374
DIN(s): 02446626, 02446634
Manufacturer: Bristol-Myers Squibb Canada
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2023-12-22
Decision / Authorization Date: 2024-06-28
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1719926004455
Product Type: Drug
Control Number: 275762
DIN(s): 02548984
Manufacturer: Valneva Austria GmbH
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2023-05-29
Decision / Authorization Date: 2024-06-20